Literature DB >> 8870820

Different binding and degradation of proinsulin, insulin and insulin-like growth factor-1 (IGF-1) in cultured renal proximal tubular cells. Implications for the prolonged serum half-life of proinsulin.

P M Jehle1, R D Fussgänger, S Stracke, R W Grunewald, F Keller.   

Abstract

Recent studies have reported that elevated proinsulin levels are indicative of an increased cardiovascular risk. Renal proximal tubular cells represent a major site for the metabolism of insulin-like hormones after glomerular filtration into the tubular lumen. To determine the binding and degradation of proinsulin in comparison with insulin and insulin-like growth factor-1 (IGF-1), we have used a rabbit proximal tubular cell line (PT-1). As confirmed by electron microscopy. PT-1 cells exhibit bipolar differentiation, demonstrating apical microvilli and invaginations of the basolateral membrane. To allow selective incubation of both compartments, cells were grown on filter membranes. Performing equilibrium binding assays with 125I-labelled hormones, severalfold higher binding was found at the apical than at the basolateral cell membrane, with the capacity range IGF-1 > insulin > proinsulin. Half-maximal displacement of 125I-labelled insulin and IGF-1 was observed at 0.6 and 2 nM, respectively, while crossover binding to the alternate receptor occurred with a 10- to 100-fold lower affinity. Half-maximal displacement of 125I-proinsulin binding was obtained at approx. 8 nM proinsulin and insulin, whereas IGF-1 was 10-fold less potent. The relative degradation of specifically bound tracer was lowest for proinsulin (apical 10%, basolateral: 13%). IGF-1 was degraded by 20% at the apical cell membrane, and up to 78% at the basolateral membrane. In contrast, almost the total amount of insulin bound was degraded at both membrane sites (apical 99%, basolateral: 83%). These results suggest separate insulin and IGF-1 receptors while proinsulin binds with high affinity to a third insulin-like receptor on the apical membrane of PT-1 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870820     DOI: 10.1007/bf00569428

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  26 in total

1.  Role of insulin and IGF1 receptors in proliferation of cultured renal proximal tubule cells.

Authors:  B L Blazer-Yost; M Watanabe; T P Haverty; F N Ziyadeh
Journal:  Biochim Biophys Acta       Date:  1992-02-03

2.  Hyperproinsulinemia in type II diabetes.

Authors:  R M Cohen; D M Nathan; R S Clements
Journal:  Diabetes Care       Date:  1992-05       Impact factor: 19.112

3.  Direct measurement of plasma proinsulin in normal and diabetic subjects.

Authors:  W C Duckworth; A E Kitabchi
Journal:  Am J Med       Date:  1972-10       Impact factor: 4.965

4.  Internalization and catabolism of insulin by an established renal cell line.

Authors:  C Yagil; B H Frank; R Rabkin
Journal:  Am J Physiol       Date:  1988-06

Review 5.  Proinsulin and C-peptide: a review.

Authors:  A E Kitabchi
Journal:  Metabolism       Date:  1977-05       Impact factor: 8.694

6.  Potency of biosynthetic human insulin determined in vitro.

Authors:  R D Fussgaenger; H H Ditschuneit; H Martini; H Wiebauer-De Lenardis; H Etzrodt; C Thun; H Ditschuneit; E F Pfeiffer; F Enzmann
Journal:  Diabetes Care       Date:  1981 Mar-Apr       Impact factor: 19.112

7.  Qualitative dissimilarities of insulin and proinsulin binding and action in vitro at IM 9-lymphocytes.

Authors:  U W Rausch; R D Fussgänger; E Heinze
Journal:  Horm Metab Res Suppl       Date:  1988

Review 8.  Interaction of insulin with the renal proximal tubular cell.

Authors:  M R Hammerman
Journal:  Am J Physiol       Date:  1985-07

9.  Insulin binding and degradation by luminal and basolateral tubular membranes from rabbit kidney.

Authors:  Z Talor; D S Emmanouel; A I Katz
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

Review 10.  Role of insulin resistance in human disease (syndrome X): an expanded definition.

Authors:  G M Reaven
Journal:  Annu Rev Med       Date:  1993       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.